MAQAF Stock Chart & Stats
$3.42
-$0.66(-16.67%)
At close: 4:00 PM EDT
$3.42
-$0.66(-16.67%)
Day’s Range― - ―
52-Week Range$2.45 - $4.09
Previous CloseN/A
Volume500.00
Average Volume (3M)13.00
Market Cap
$3.84B
Enterprise Value$8.79B
Total Cash (Recent Filing)$214.00M
Total Debt (Recent Filing)$1.61B
Price to Earnings (P/E)20.1
Beta0.23
Next Earnings
Feb 24, 2027EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield8.47%
Share Statistics
EPS (TTM)0.19
Shares Outstanding1,453,493,400
10 Day Avg. Volume20
30 Day Avg. Volume13
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.22
Price to Sales (P/S)44.25
P/FCF Ratio11.54
Enterprise Value/Market Cap2.29
Enterprise Value/Revenue56.08
Enterprise Value/Gross Profit-1.47K
Enterprise Value/Ebitda233.25
Forecast
1Y Price Target
$3.23Price Target Upside-5.49% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)0.13
Revenue Forecast (FY)$129.76M
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationStronger operating and free cash flow improves Atlas Arteria’s ability to fund maintenance, service infrastructure debt, and support distributions internally. Better cash conversion also provides resilience across its long-term concession portfolio, although historical volatility means sustainability should remain monitored.
Recurring Toll-road Economics With Resilient Underlying GrowthLong-term concessions provide recurring access to toll revenue, while inflation-linked pricing can protect the economic value of cash flows. Recent constant-currency revenue and EBITDA growth indicates the portfolio is maintaining operating resilience despite mixed traffic conditions.
Strengthened Liquidity And Financing FlexibilityRecent financing actions and retained liquidity give Atlas Arteria greater flexibility to meet obligations, manage concession-level funding needs, and pursue planned capital actions. This supports balance-sheet resilience and reduces dependence on immediate operating cash flow during periods of volatility.
Bears Say
Inconsistent Underlying Operating ProfitabilityWeak and volatile EBIT makes reported earnings less dependable as a measure of recurring operating performance. If operating margins remain inconsistent, Atlas Arteria may have less predictable capacity to fund distributions, reinvest in assets, and absorb changes in traffic or operating costs.
Foreign-exchange Exposure Reduces Reported ResultsThe portfolio’s euro and U.S.-dollar exposure can materially reduce reported revenue, EBITDA, and cash receipts when translated into Australian dollars. This creates ongoing variability in consolidated performance and can complicate distribution planning even when local operations remain stable.
Governance And Long-term Strategy UncertaintyA controlling ownership change combined with withdrawn multi-year targets and paused expansion leaves the company’s capital-allocation path less defined. Reduced visibility may constrain strategic execution and make future growth, distributions, and governance priorities harder to assess over the next several periods.
Atlas Arteria News
MAQAF FAQ
What was Atlas Arteria’s price range in the past 12 months?
Atlas Arteria lowest stock price was $2.45 and its highest was $4.09 in the past 12 months.
What is Atlas Arteria’s market cap?
Atlas Arteria’s market cap is $3.84B.
When is Atlas Arteria’s upcoming earnings report date?
Atlas Arteria’s upcoming earnings report date is Feb 24, 2027 which is in 140 days.
How were Atlas Arteria’s earnings last quarter?
Atlas Arteria released its earnings results on Aug 26, 2026. The company reported -$0.037 earnings per share for the quarter, missing the consensus estimate of $0.037 by -$0.073.
Is Atlas Arteria overvalued?
According to Wall Street analysts Atlas Arteria’s price is currently Overvalued.
Does Atlas Arteria pay dividends?
Atlas Arteria pays a Semiannually dividend of $0.14 which represents an annual dividend yield of 8.47%. See more information on Atlas Arteria dividends here
What is Atlas Arteria’s EPS estimate?
Atlas Arteria’s EPS estimate is 0.12.
How many shares outstanding does Atlas Arteria have?
Atlas Arteria has 1,453,493,400 shares outstanding.
What happened to Atlas Arteria’s price movement after its last earnings report?
Atlas Arteria reported an EPS of -$0.037 in its last earnings report, missing expectations of $0.037. Following the earnings report the stock price went down -1.301%.
Which hedge fund is a major shareholder of Atlas Arteria?
Currently, no hedge funds are holding shares in MAQAF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Atlas Arteria Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.23 (-5.49% Downside)
$3.23 (-5.49% Downside)
Blogger Sentiment
Neutral
MAQAF Sentiment 50%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth $264.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.37%
12-Months-Change
Fundamentals
Return on Equity
8.47%
Trailing 12-Months
Asset Growth
-5.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Atlas Arteria
Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer Dulles Greenway toll road, situated in Virginia, United States. The company was established in 2009 and operates from its corporate headquarters in Melbourne, Australia. It formally rebranded from Macquarie Atlas Roads Limited to its current name, Atlas Arteria Limited, in May 2018.
MAQAF Company Deck
MAQAF Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture. Operationally the portfolio showed resilience — underlying NPAT rose 29%, constant-currency revenue and EBITDA were marginally positive, Dulles and Chicago traffic grew, APRR issued EUR 500m of bonds, and the company maintained its $0.40 distribution guidance while strengthening liquidity. Offsetting this were sizable one-off non-operating charges (put option accounting and settlement, takeover and change-of-control costs), adverse FX translating to a ~3.9% revenue and ~3.6% EBITDA decline in AUD terms, a TRIP bond downgrade, and governance/ownership uncertainty following IFM increasing its stake to ~67%. Overall the operational positives are meaningful but balanced by significant near-term headwinds and one-off costs, leaving the tone cautiously neutral.View all MAQAF earnings summariesMAQAF Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$3.23
▼(-5.49% Downside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
―
Brambles
―
Aurizon Holdings
―
Transurban Group
―
Dalrymple Bay Infrastructure Ltd.
―
Ownership Overview
0.08% Insiders
8.44% Mutual Funds
<0.01% Other Institutional Investors
87.28% Public Companies and
Individual Investors




